Compound ID | 809
Class: Oxazolidinone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Demonstrates activity against MRSA, VRE, M. catarrhalis and S. pneumoniae.No development has been reported since 2011 |
| Institute where first reported: | Orchid Chemicals & Pharmaceuticals, India |
| Year first mentioned: | 2011 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |